公开(公告)号：US20220184149A1

公开(公告)日：2022-06-16

申请号：US16094856

申请日：2017-04-19

Applicant: Genome Research Limited

Inventor： Anne NEVILLE ,  Hilary BROWNE ,  Sam FORSTER ,  Trevor LAWLEY

IPC: A61K35/742 ,  A61P31/04 ,  A61P1/04 ,  A61P1/14 ,  A61P1/16 ,  A61P1/06 ,  A61K9/00

Abstract: The invention relates to therapeutic compositions comprising at least one isolated bacterium and a pharmaceutically acceptable excipient, as well as methods of preparing such therapeutic compositions. The therapeutic compositions find application in the treatment of dysbiosis, in particular dysbiosis of the gastrointestinal tract.

公开(公告)号：US20240156880A1

公开(公告)日：2024-05-16

申请号：US18446994

申请日：2023-08-09

Applicant: Genome Research Limited

Inventor： Anne NEVILLE ,  Hilary BROWNE ,  Sam FORSTER ,  Trevor LAWLEY

IPC: A61K35/742 ,  A61K9/00 ,  A61P1/04 ,  A61P1/06 ,  A61P1/14 ,  A61P1/16 ,  A61P31/04

CPC classification number: A61K35/742 ,  A61K9/0031 ,  A61K9/0053 ,  A61P1/04 ,  A61P1/06 ,  A61P1/14 ,  A61P1/16 ,  A61P31/04

Abstract: The invention relates to therapeutic compositions comprising at least one isolated bacterium and a pharmaceutically acceptable excipient, as well as methods of preparing such therapeutic compositions. The therapeutic compositions find application in the treatment of dysbiosis, in particular dysbiosis of the gastrointestinal tract.